X-108686130-G-A
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_033380.3(COL4A5):c.4315+1G>A variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000167 in 1,196,899 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_033380.3 splice_donor, intron
Scores
Clinical Significance
Conservation
Publications
- Alport syndromeInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen, G2P
- X-linked Alport syndromeInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Genomics England PanelApp, Myriad Women’s Health, Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| COL4A5 | NM_033380.3 | c.4315+1G>A | splice_donor_variant, intron_variant | Intron 48 of 52 | ENST00000328300.11 | NP_203699.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| COL4A5 | ENST00000328300.11 | c.4315+1G>A | splice_donor_variant, intron_variant | Intron 48 of 52 | 1 | NM_033380.3 | ENSP00000331902.7 |
Frequencies
GnomAD3 genomes AF: 0.00000897 AC: 1AN: 111516Hom.: 0 Cov.: 23 show subpopulations
GnomAD2 exomes AF: 0.00000560 AC: 1AN: 178644 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 9.21e-7 AC: 1AN: 1085383Hom.: 0 Cov.: 27 AF XY: 0.00 AC XY: 0AN XY: 351207 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000897 AC: 1AN: 111516Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33676 show subpopulations
ClinVar
Submissions by phenotype
not provided Pathogenic:3
Published functional studies demonstrate that the variant results in partial skipping of exon 46 (PMID: 15780079); Canonical splice site variant predicted to result in an in-frame loss of the adjacent exon in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 35372954, 25525159, 35580552, 15780079)
For these reasons, this variant has been classified as Pathogenic. This variant disrupts the triple helix domain of COL4A5. Glycine residues within the Gly-Xaa-Yaa repeats of the triple helix domain are required for the structure and stability of fibrillar collagens (PMID: 7695699, 8218237, 19344236). In COL4A5, missense variants at these glycine residues are significantly enriched in individuals with disease (PMID: 23720012, 27627812) compared to the general population (ExAC). Studies have shown that disruption of this splice site results in the activation of a cryptic splice site in exon 46 (PMID: 15780079). ClinVar contains an entry for this variant (Variation ID: 24725). This variant is also known as g.4499+1G>A. Disruption of this splice site has been observed in individual(s) with Alport syndrome (PMID: 15780079). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the ExAC database. This sequence change affects a donor splice site in intron 46 of the COL4A5 gene. RNA analysis indicates that this variant induces altered splicing and likely results in the loss of 6 amino acid residue(s), but is expected to preserve the integrity of the reading-frame.
DNA sequence analysis of the COL4A5 gene demonstrated a sequence change in the canonical splice donor site/splice acceptor site of intron 46, c.4297+1G>A. This sequence change has been previously described in an individual with COL4A5-related Alport syndrome (PMID: 15780079) and in an individual with sensorineural hearing loss (PMID: 35580552). This sequence change has been described in the gnomAD database in two individuals with XX chromosome complement, which corresponds to an overall population frequency of 0.001% (dbSNP rs587776403). This pathogenic sequence change is predicted to affect normal splicing of the COL4A5 gene and result in an abnormal protein. RNA studies show that this sequence change results in partial skipping of exon 46 (PMID: 15780079), including several amino acid residues known to be critical for COL4A5 protein function (PMID: 7695699, 8218237, 19344236). These collective evidences indicate that this sequence change is pathogenic.
X-linked Alport syndrome Pathogenic:3
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at